Pharmacoresistance in Epilepsy : From Genes and Molecules to Promising Therapies /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Rocha, Luisa. (Editor ), Cavalheiro, Esper A. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer New York : Imprint: Springer, 2013.
Edición:1st ed. 2013.
Materias:
LEADER 02802nam a22003375i 4500
001 000288081
005 20210908133143.0
007 cr nn 008mamaa
008 130507s2013 xxu| s |||| 0|eng d
020 |a 9781461464648 
024 7 |a 10.1007/978-1-4614-6464-8  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Pharmacoresistance in Epilepsy :  |b From Genes and Molecules to Promising Therapies /  |c edited by Luisa Rocha, Esper A. Cavalheiro. 
250 |a 1st ed. 2013. 
260 # # |a New York, NY :  |b Springer New York :  |b Imprint: Springer,  |c 2013. 
300 |a XII, 329 p. :  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
505 0 |a Pharmacoresistance and Epilepsy -- Genes involved in pharmacoresistant epilepsy -- Pathological oscillations in the pharmacoresistant epileptic brain -- Molecular mechanisms of pharmacoresistant epilepsy -- Modifications in the seizures susceptibility by excitotoxic neuronal damage and its possible relationship with the pharmacoresistance -- Intracellular pathways associated with neuronal survival and death in epilepsy -- The role of JNK pathway in the process of excitotoxicity induced by epilepsy and neurodegeneration -- Proteomics-based strategy to identify biomarkers and pharmacological targets in temporal lobe epilepsy -- Abnormalities of GABA system and human pharmacoresistant epilepsy -- Pharmacoresistant epilepsy and immune system -- Contribution of the antiepileptic drug administration regime in the development and/or establishment of pharmacoresistant epilepsy -- Experimental models to study pharmacoresistance in epilepsy -- Resistance to epileptogenesis in the Neotropical rodent Proechimys -- On the development of new antiepileptic drugs for the treatment of pharmacoresistant epilepsy – Different approaches to different hypothesis -- Modulating P-glycoprotein regulation as a therapeutic strategy for pharmacoresistant epilepsy -- Vagus Nerve Stimulation for Intractable Seizures -- The role of neuromodulation in the treatment of refractory epilepsy -- Transcranial magnetic stimulation and refractory partial epilepsy -- Effects of transcranial focal electrical stimulation via concentric ring electrodes on seizure activity -- Physical exercise as a strategy to reduce seizure susceptibility. 
650 0 |a Neurosciences. 
650 0 |a Neurology . 
650 0 |a Pharmacology. 
650 1 4 |a Neurosciences. 
650 2 4 |a Neurology. 
650 2 4 |a Pharmacology/Toxicology. 
700 1 |a Rocha, Luisa.  |e editor. 
700 1 |a Cavalheiro, Esper A.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
900 |a Libro descargado a ALEPH en bloque (proveniente de proveedor)